Photobiomodulation therapy (PBMT) is a safe and effective option for multiple skin diseases. To promote standardized clinical use, this expert consensus was developed by 35 dermatology experts through two rounds of Delphi surveys and addressed 19 clinical questions with a consensus degree of over 80%. This consensus summarizes current evidence on PBMT’s mechanisms of action, indications, contraindications, treatment parameters, and adverse event management. Although encouraging outcomes have been observed regarding acne vulgaris, photoaging, alopecia, and other dermatologic conditions, considerable variability in treatment protocols and the scarcity of high-quality, large-scale clinical trials continue to limit broader clinical adoption. This consensus provides evidence-based and practical guidance to support the safe and effective incorporation of PBMT into dermatologic practice in China.
Bo et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: